| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
|
Khreish, Fadi
|
|
|
47 |
3 |
p. 721-728
|
artikel
|
| 2 |
Assessment of the impact of 2015 American Thyroid Association guidelines in management of differentiated thyroid cancer patients
|
Choudhury, Sayak
|
|
|
47 |
3 |
p. 547-553
|
artikel
|
| 3 |
ATLAS OF PET-CT, A Quick Guide to Image Interpretation
|
Carrió, Ignasi
|
|
|
47 |
3 |
p. 515-516
|
artikel
|
| 4 |
Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
|
Pan, Qingqing
|
|
|
47 |
3 |
p. 537-546
|
artikel
|
| 5 |
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks
|
Rasul, Sazan
|
|
|
47 |
3 |
p. 713-720
|
artikel
|
| 6 |
Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study
|
Kwon, Seong Young
|
|
|
47 |
3 |
p. 561-571
|
artikel
|
| 7 |
Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
|
Maffey-Steffan, Johanna
|
|
|
47 |
3 |
p. 740
|
artikel
|
| 8 |
Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT
|
Zhao, Yu
|
|
|
47 |
3 |
p. 603-613
|
artikel
|
| 9 |
Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield
|
Montes de Jesus, F. M.
|
|
|
47 |
3 |
p. 529-536
|
artikel
|
| 10 |
Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison
|
Alberts, Ian
|
|
|
47 |
3 |
p. 614-623
|
artikel
|
| 11 |
Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies
|
Verburg, Frederik A.
|
|
|
47 |
3 |
p. 519-522
|
artikel
|
| 12 |
Extranodal involvement of multiple organs in diffuse large B cell lymphoma detected on 18F-FDG PET/CT
|
Song, Tianbin
|
|
|
47 |
3 |
p. 734-735
|
artikel
|
| 13 |
18F-FDG PET/CT in patients with post-transplant lymphoproliferative disorders: so far so good
|
Treglia, Giorgio
|
|
|
47 |
3 |
p. 523-524
|
artikel
|
| 14 |
[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0
|
Nanni, Cristina
|
|
|
47 |
3 |
p. 579-591
|
artikel
|
| 15 |
18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!
|
Treglia, Giorgio
|
|
|
47 |
3 |
p. 527-528
|
artikel
|
| 16 |
18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer
|
Sachpekidis, Christos
|
|
|
47 |
3 |
p. 592-602
|
artikel
|
| 17 |
68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer—a modified protocol compared with the common protocol
|
Haupt, Fabian
|
|
|
47 |
3 |
p. 624-631
|
artikel
|
| 18 |
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
|
Ferraro, Daniela A.
|
|
|
47 |
3 |
p. 652-664
|
artikel
|
| 19 |
Isolated involvement of thyroid gland by IgG4-related disease revealed by 18F-FDG PET/CT
|
Jiang, Yuanyuan
|
|
|
47 |
3 |
p. 736-737
|
artikel
|
| 20 |
Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
|
Duarte, Paulo Schiavom
|
|
|
47 |
3 |
p. 525-526
|
artikel
|
| 21 |
New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide
|
Rosar, Florian
|
|
|
47 |
3 |
p. 687-694
|
artikel
|
| 22 |
Planar scan vs. SPECT/low-dose CT for estimating split renal function by 99mTc-DMSA scintigraphy in children
|
Reichkendler, Michala Holm
|
|
|
47 |
3 |
p. 729-733
|
artikel
|
| 23 |
Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer
|
Ettala, Otto
|
|
|
47 |
3 |
p. 665-673
|
artikel
|
| 24 |
Radiology and nuclear medicine: advancing together in the era of precision medicine
|
Chiti, Arturo
|
|
|
47 |
3 |
p. 517-518
|
artikel
|
| 25 |
Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas
|
López-Mora, Diego Alfonso
|
|
|
47 |
3 |
p. 572-578
|
artikel
|
| 26 |
Superior performance of 18F-fluorocholine digital PET/CT in the detection of parathyroid adenomas
|
López-Mora, Diego Alfonso
|
|
|
47 |
3 |
p. 572-578
|
artikel
|
| 27 |
The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients
|
Onal, Cem
|
|
|
47 |
3 |
p. 632-641
|
artikel
|
| 28 |
The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
|
Maffey-Steffan, Johanna
|
|
|
47 |
3 |
p. 695-712
|
artikel
|
| 29 |
The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer
|
Kulkarni, Meghana
|
|
|
47 |
3 |
p. 674-686
|
artikel
|
| 30 |
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia
|
Alberts, Ian
|
|
|
47 |
3 |
p. 642-651
|
artikel
|
| 31 |
Variations in radioiodine ablation: decision-making after total thyroidectomy
|
Maas, O.
|
|
|
47 |
3 |
p. 554-560
|
artikel
|
| 32 |
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
|
de Keizer, Bart
|
|
|
47 |
3 |
p. 738-739
|
artikel
|
Tijdschrift beschrijving